These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24749813)

  • 1. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors.
    Muñoz de Escalona Rojas JE; García Serrano JL; Cantero Hinojosa J; Padilla Torres JF; Bellido Muñoz RM
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):489-94. PubMed ID: 24749813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Karp CL; Moore JK; Rosa RH
    Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia].
    Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L
    Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
    Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
    BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
    Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
    Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
    Esquenazi S; Fry CL; Holley E
    Br J Ophthalmol; 2005 Sep; 89(9):1221. PubMed ID: 16113387
    [No Abstract]   [Full Text] [Related]  

  • 16. Conjunctival intraepithelial neoplasia. Interferon as a rescue therapy after failure of mitomycin C.
    de la Cruz Aguiló RI; Duch-Samper A; Hernández Pérez D; Marí Cotino J
    Arch Soc Esp Oftalmol; 2014 Nov; 89(11):463-5. PubMed ID: 24377953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
    Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
    Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
    Pagán Carrasco S; Arranz Maestro D
    Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.